OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
BMKDF
Biomark Diagnostics Inc.
Ordinary Shares
0.23535
0.00375
1.62%
0.2293 / 0.2444 (7500 x 27500)
Real-Time Best Bid & Ask: 05:00pm 06/16/2025
Delayed (15 Min) Trade Data: 12:00am 06/16/2025
0.23535
0.23535 - 0.23535
100
Market Cap calculated only for this class of securities.
24,732,982
Real-Time Level 2 Quote
Bid
Ask
MPID MPID | Bid Price Bid Price | Size Size | Time Time |
|---|---|---|---|
Virtu Americas LLC | 0.2293 | 5,000 | 06/16 |
VIRTU Americas LLC | 0.2293 | 2,500 | 06/16 |
G1 Execution Services, LLC | 0.226 | 2,500 | 06/16 |
StoneX Financial Inc. | 0.2156 | 2,500 | 06/16 |
MCAP LLC | 0.1767 | 5,000 | 06/16 |
MPID MPID | Ask Price Ask Price | Size Size | Time Time |
|---|---|---|---|
Virtu Americas LLC | 0.2444 | 25,000 | 06/16 |
VIRTU Americas LLC | 0.2444 | 2,500 | 06/16 |
G1 Execution Services, LLC | 0.245 | 2,500 | 06/16 |
StoneX Financial Inc. | 0.2593 | 2,500 | 06/16 |
GTS Securities LLC | 0.2716 | 2,500 | 06/06 |
Trade Data
Date Date | Timestamp Timestamp | Price Price | $ Change $ Change | Volume Volume |
|---|---|---|---|---|
| 06/16/2025 | 15:43:04 | 0.23535 | 0.00 | 100 |
| 06/13/2025 | 15:56:28 | 0.2316 | 0.00 | 1,000 |
| 06/13/2025 | 15:56:15 | 0.2316 | 0.00 | 500 |
| 06/13/2025 | 15:45:11 | 0.2316 | -0.00 | 6,500 |
| 06/06/2025 | 13:42:01 | 0.23166 | -0.01 | 700 |
News
More
Filings and Disclosure
Management Discussion and Analysis02/27/2017
Interim Financial Report02/27/2017
Management Discussion and Analysis11/29/2016
Company Description
BioMark is a Canadian based company that is developing its advanced stage cancer diagnostic business. BioMark's cancer diagnostics technology platform leverages "Omics" and machine learning which allows for early cancer detection. BioMark is currently focused on bringing its cancer diagnostic and detection solution starting with its lung cancer assay to commercialization standards. It intends to commence distribution after securing its lab certification and regulatory acceptance is obtained. For more information please visit the company's website at www.biomarkdiagnostics.com
Videos
This company has not added any videos
Joined OTCQB 04/2017
The Company Profile data was verified by the issuer within the previous 6 months.
This company has certified to OTC Markets Group that it is eligible to rely on the exemption from registration under Securities and Exchange Act Rule 12g3-2(b).
The Company’s board of directors includes at least two Independent Directors.
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
51.00
Change
-0.15 (-0.29%)
Bid
50.25
Ask
51.40
Volume
8063
Time
00:00
